Valneva and Pfizer have announced that the two companies have entered into an Equity Subscription Agreement and have updated their Collaboration and License Agreement terms for the Lyme disease vaccine candidate, VLA15. As previously announced, Pfizer plans to begin Phase 3 studies of VLA15 in Q3 2022.
Robert C. Bransfield, MD, published a study examining how adverse childhood events (ACE), post-traumatic stress disorder (PTSD), and infectious encephalopathies are linked to immune-mediated disease in the journal, Healthcare. Bransfield reviewed supporting data and found that each of these issues correlates with intrusive symptoms and pathology of the temporal lobe.
A study published in Clinical Infectious Diseases, by Ralph Rogers, et al., examined
antimicrobial resistance in an immunocompromised patient with relapsing babesiosis who was effectively treated with tafenoquine.
Yang Dong, et al. reported on the results of a study that was designed to estimate seroprevalence and sociodemographic characteristics
of Borrelia Burgdorferi Sensu Lato (Bb) in human populations, globally. The results, published in BMJ Global Health, consist of the systematic review and meta-analysis of numerous relevant studies culled from PubMed, Embase, Web of Science, and other sources.
The Lyme Disease Association, Inc. LDA has been designated as a national charity included in the 2022 Combined Federal Campaign (CFC) National/International Charity List. CFC is part of the Office of Personnel Management (OPM). Each year, federal employees are provided with lists of approved charities for their workplace giving through the CFC. The LDA has […]
May Awareness LDA Guest Blogger Thomas Platts-Mills MD, PhD, FRCP, FRS trained in Oxford and after completing Medical Residency in the UK went to Johns Hopkins to train in Allergy and Immunology. From 1974-1982 he worked for the Medical Research Council in London and carried out the seminal studies on the dust mite allergen Der […]
Please join the Tick IPM Working Group June 24, 2022, for the third annual Tick Academy! The Tick Academy is the premier event for pest control professionals, educators, students, researchers, public health professionals, public-space managers and citizen scientists interested in learning more about what they can do to stop the spread of ticks and tick-borne diseases in their communities.
Dr. Jones/Societal Cost/CD4 T Cells/Horowitz/Trauma & Loss/Lyme & Mental Illness/Alpha-gal/Tick Bites/B. Duncani/Lyme Vax/$10M LymeX Prize/Cat Owners/Tick Stik/County Levels/Bullous EM/Pat Smith Video
Sometimes we are blessed to have great men walk the earth – men and women who devote their lives to helping others without thought for themselves. Such a man was Dr. Charles Ray Jones, healer. He was honest, kind, courageous and had integrity, compassion, and humility. His devotion to helping our children all over the country is unparalleled. I knew him for decades yet never heard a complaint from him despite the many trials he faced in his life just trying to save the lives of our children.
Journal of Medical Entomology published, “Reported County-Level Distribution of Seven
Human Pathogens Detected in Host-Seeking Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the Contiguous United States” by Amy C. Fleshman, et al.
A study conducted by Elizabeth M. Hammond, et al., examining CD4 T cell responses associated with persistent B. burgdorferi (Bb) infections, has been published in Current Opinion in Immunology.